ESR1 and breast carcinoma: It has been reported that limonin has cytotoxic effects on estrogen receptor (ER)-positive (MCF-7) and estrogen receptor (ER)-negative (MDA-MB-231) human breast cancer cells, possibly by activating caspase-7-dependent pathway to achieve inhibition of proliferation activity [27].